Cargando…
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response
The majority of lncRNAs’ roles in tumor immunology remain elusive. This project performed a CRISPR activation screening of 9744 lncRNAs in melanoma cells cocultured with human CD8(+) T cells. We identified 16 lncRNAs potentially regulating tumor immune response. Further integrative analysis using tu...
Autores principales: | Wang, Yifei, Zhao, Yueshan, Guo, Weiwei, Yadav, Ghanshyam Singh, Bhaskarla, Chetana, Wang, Zehua, Wang, Xiaofei, Li, Sihan, Wang, Yue, Chen, Yuang, Pattarayan, Dhamotharan, Xie, Wen, Li, Song, Lu, Binfeng, Kammula, Udai S., Zhang, Min, Yang, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728976/ https://www.ncbi.nlm.nih.gov/pubmed/36475797 http://dx.doi.org/10.1126/sciadv.add0005 |
Ejemplares similares
-
lncRNA-GM targets Foxo1 to promote T cell–mediated autoimmunity
por: Chen, Yali, et al.
Publicado: (2022) -
LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein
por: Cai, Zijie, et al.
Publicado: (2023) -
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer
por: Wang, Yue, et al.
Publicado: (2023) -
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
por: Wan, Zhuoya, et al.
Publicado: (2021) -
Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
por: Zhang, Jiayu, et al.
Publicado: (2023)